Literature DB >> 12061947

The corticomotor threshold is not dependent on disease duration in amyotrophic lateral sclerosis (ALS).

Mamede de Carvalho1, Teresinha Evangelista, M L Sales-Luís.   

Abstract

INTRODUCTION: It is suggested that early in ALS the corticomotor threshold (CMT) is low, but increases with increasing duration of the disease. POPULATION AND METHODS: We compared CMT, central conduction time and motor-evoked response/M-wave amplitude in two populations of ALS patients: one with disease duration shorter than 6 months (Group A, 11 patients) and another who had had the disease for more than 24 months (Group B, 14 patients). These two groups were compared with a control group of 30 subjects. In all the ALS patients, abductor digiti minimi (ADM) strength was greater than MRC 3.
RESULTS: M-wave amplitude was comparable in the three groups. We found no difference between the three groups in these transcranial magnetic stimulation studies and there was no correlation between disease duration time and CMT.
CONCLUSION: We did not confirm a relation between CMT and disease duration. An increased CMT late in the disease progression is associated with greater lower motor neuron loss, and greater corticospinal tract degeneration with dispersion of the descending motor volley.

Entities:  

Mesh:

Year:  2002        PMID: 12061947     DOI: 10.1080/146608202317576525

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  5 in total

1.  A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.

Authors:  Michael D Weiss; Eric A Macklin; Zachary Simmons; Angela S Knox; David J Greenblatt; Nazem Atassi; Michael Graves; Nicholas Parziale; Johnny S Salameh; Colin Quinn; Robert H Brown; Jane B Distad; Jaya Trivedi; Jeremy M Shefner; Richard J Barohn; Alan Pestronk; Andrea Swenson; Merit E Cudkowicz
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

Review 2.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

3.  Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.

Authors:  M R Turner; A D Osei-Lah; A Hammers; A Al-Chalabi; C E Shaw; P M Andersen; D J Brooks; P N Leigh; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

4.  Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.

Authors:  Olivia Schanz; Devin Bageac; Laura Braun; Bryan J Traynor; Tanya J Lehky; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2016-05-25       Impact factor: 3.217

5.  Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.

Authors:  Michael D Weiss; Eric A Macklin; Courtney E McIlduff; Steve Vucic; Brian J Wainger; Matthew C Kiernan; Stephen A Goutman; Namita A Goyal; Seward B Rutkove; Shafeeq S Ladha; I-Hweii Amy Chen; Matthew B Harms; Thomas H Brannagan; David Lacomis; Sasha Zivkovic; Maxwell Ma; Leo H Wang; Zachary Simmons; Michael H Rivner; Jeremy M Shefner; Merit E Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2020-12-31       Impact factor: 3.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.